Reported cashflow from operations totaled $154.7 million through the third quarter of fiscal year 2014, in comparison to reported cashflow from operations of $145.2 million for the 3rd quarter of fiscal season 2013. Free cashflow was $94.4 million, including $100.4 million of cash interest paid in the quarter, in comparison to a free cashflow of $102.4 million through the third quarter of fiscal year 2013, including $97.5 million of cash interest paid. Unlevered free cashflow was $194.8 million through the third quarter of fiscal year 2014, in comparison to $199.9 million for the 3rd quarter of fiscal year 2013.4 million, leading to net debt of $5,619.3 million, in comparison to $5,610.8 million at May 31, 2013. Biomet's President and CEO Jeffrey R.Sankaran to receive Rising Superstar AwardResearchers develop new growth charts for U.S. Children with Down syndrome Main depressive disorder can be common in children and adolescents and has significant negative impacts on children's development, working and risk for suicide, Cooper said. Based on the American Academy of Adolescent and Child Psychiatry, suicide may be the third leading reason behind death for 15-24 calendar year olds and the 6th leading reason behind death for 5-14 year olds. The Vanderbilt research reviewed the medical information of 36,842 children 6 to 18 years old enrolled in Medicaid between 1995 and 2006 who were fresh users of one of the antidepressant medications of interest. Of these studied 415 acquired a medically treated suicide attempt, including four who completed suicide.